Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iRhythm HoldingsIRTC +4.46%76 3-1 Month Momentum % is -1.93% as of Jul. 30, 2026. GuruFocus rates IRTC with a GF Score™ of 76/100 and a GF Value™ of $165.06 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 849 Medical Devices & Instruments companies, iRhythm Holdings ranks better than 61.72% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-30), iRhythm Holdings's 3-1 Month Momentum % is -1.93%.
The industry rank for iRhythm Holdings's 3-1 Month Momentum % or its related term are showing as below:
IRTC's 3-1 Month Momentum % is ranked better than 61.72% of 849
companies
in the Medical Devices & Instruments industry
Industry Median: -7.08
vs IRTC: -1.93
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
iRhythm Holdings 3-1 Month Momentum % Related Terms
IRTC vs HAE, ITGR, LIVN: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, iRhythm Holdings's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Holdings 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Holdings's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where iRhythm Holdings's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRhythm Holdings (IRTC) has a 3-1 Month Momentum % of -1.93% as of Jul. 30, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on iRhythm Holdings and its competitors. According to the industry distribution chart, iRhythm Holdings ranks #325 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 38.3%.
Is iRhythm Holdings' 3-1 Month Momentum % too high?
iRhythm Holdings' current 3-1 Month Momentum % is -1.93%. Based on the distribution chart, iRhythm Holdings ranks #325 out of 849 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, iRhythm Holdings has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRhythm Holdings' 3-1 Month Momentum % compare to HAE and ITGR?
According to the Medical Devices & Instruments industry distribution chart, iRhythm Holdings ranks #325 out of 849 companies for 3-1 Month Momentum %. This puts iRhythm Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on iRhythm Holdings and its competitors. iRhythm Holdings's current 3-1 Month Momentum % is -1.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRhythm Holdings stock overvalued right now?
Based on GuruFocus' analysis, iRhythm Holdings (IRTC) is currently considered Modestly Undervalued. The stock's GF Value™ is $165.06, compared to a current price of $122.53 — trading 25.8% below its estimated fair value. The current 3-1 Month Momentum % is -1.93%. iRhythm Holdings' overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For iRhythm Holdings (IRTC), the current 3-1 Month Momentum % is -1.93% as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRhythm Holdings (IRTC) Overvalued in 2026?
Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued.
The current stock price of $122.53 is trading 25.8% below its estimated GF Value™ of $165.06.
GuruFocus considers iRhythm Holdings to be Modestly Undervalued.
Key valuation signals for IRTC:
3-1 Month Momentum %: -1.93%
GF Value™: $165.06 vs. price of $122.53 (25.8% below fair value)
No single metric tells the full story. See the IRTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
76GF Score
Get the complete analysis for IRTC
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRTC has been successfully added to your 
